findmyKOL

Francis Yao, MD

Basic profile

University of California, San Francisco

ORCIDNPI
RegionSan Francisco, CA · WestSpecialtyGastroenterologyFocusGastroenterology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Francis Yao is a Gastroenterology physician affiliated with University of California, San Francisco. OpenAlex indexes 176 publications with 13,732 citations (h-index 56). By OpenAlex citation count, this profile ranks in the top 10% of Gastroenterology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
176publications

Distinct works indexed by OpenAlex, matched via ORCID.

13,732citations

Total citations across indexed works.

56h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

350 Parnassus Ave
San Francisco, CA 941430001

Telephone

415-353-2318

Registry record last updated 11 Sept 2025.

View the NPPES registry record

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    56.3%
    Nucleoside and nucleotide reverse transcriptase inhibitors38.5%
    Vemlidy94%Tenofovir Disoproxil Fumarate7%
    Part D<11 patients
    Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor17.9%
    Entecavir91%Baraclude9%
    Part D<11 patients
  • Metabolism & gastrointestinal

    26%
    Bile Acid7.2%
    Ursodiol100%
    Part D29 patients
    Proton pump inhibitor6.2%
    Omeprazole55%Pantoprazole Sodium45%
    Part D16 patients

    + 3 more classes in this area

  • Cardiovascular

    7.8%
    Statin3.5%
    Atorvastatin Calcium100%
    Part D13 patients
    Aldosterone antagonist (MRA)1.7%
    Spironolactone100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)89.4% facility · 10.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”